Why Your Melatonin Stopped Working — And What to Do Instead

Why Your Melatonin Stopped Working — And What to Do Instead

You started with one gummy. Then two. Then you switched to the 10mg tablets. Now you're taking melatonin every night and still lying awake at 1 AM, wondering if you got a bad batch.

You didn't get a bad batch. The melatonin is fine. Your expectations about what it actually does — that's where things went sideways.

I have this conversation constantly. Someone walks in frustrated — sometimes genuinely angry — because the supplement "everyone says works" just... stopped. And the answer, nearly every time, is the same: melatonin was never designed to treat insomnia in the first place.

The Melatonin Misconception

Here's what melatonin actually is: a hormone. Your pineal gland makes it when light levels drop. It tells your body "hey, it's getting dark, start winding down." That's it. It's a timing signal. Not a sedative.

That distinction matters. When you swallow a melatonin gummy, you're not knocking yourself out. You're nudging your circadian clock: "It's nighttime now." For jet lag or delayed sleep phase? Perfect tool. Exactly what it's made for.

For chronic insomnia? It's like adjusting the clock on your wall and expecting the traffic jam outside to disappear. The clock isn't the problem.

The clinical evidence reflects this. A 2022 Cochrane meta-analysis — the gold standard of evidence reviews — examined 23 randomized controlled trials and found that melatonin reduced sleep onset latency by an average of 7 minutes and increased total sleep time by 8 minutes compared to placebo (Low et al., 2022).

Seven minutes. Eight minutes. Read that again. That's the real effect size. So why did it feel like a miracle the first week? Almost certainly placebo. In insomnia studies, placebo response runs 30-40%. Your belief that it would help was doing most of the heavy lifting.

Why It Stops "Working"

Three mechanisms explain why melatonin loses its perceived effect:

1. Placebo decay. The belief that something will help is genuinely powerful — it's the strongest short-term sleep intervention in clinical trials. But it fades. Give it 2-4 weeks and the novelty wears off.
2. Receptor desensitization. This is the biological part. Melatonin doesn't build tolerance like benzos, but flooding your brain with 5-10mg (that's 10-20x what your body naturally produces — yes, really) can downregulate your MT1 and MT2 receptors. Your brain gets quieter in response to the signal. Like a neighbor who stops hearing the car alarm after the third night.
3. Dose escalation without benefit. Here's the kicker: taking more doesn't help. A 2021 study in Sleep compared 0.5mg, 3mg, and 10mg in adults with insomnia. Sleep onset? No significant difference between groups. The 10mg group did report something, though — more morning grogginess and vivid, sometimes disturbing dreams (Vural et al., 2021). So you get the side effects without the upside. Great deal.

The Unregulated Reality

Here's something that should concern you: because melatonin is classified as a dietary supplement in the US (not a drug), it's not regulated by the FDA for quality or dosage accuracy.

A landmark 2023 JAMA study tested 25 commercial melatonin products and found that actual melatonin content ranged from -83% to +478% of the labeled dose. One in four products contained serotonin — a prescription substance — as a contaminant (Cohen et al., 2023).

You might be taking 2mg when the label says 10mg. Or 47mg when it says 10mg. There's no way to know without lab testing.

For context: in the European Union, Australia, and the UK, melatonin is prescription-only, available in a standardized 2mg controlled-release formulation (Circadin). The US approach of selling unregulated 10mg gummies next to the vitamins is, from a clinical perspective, reckless.

What Chronic Insomnia Actually Needs

If your insomnia has lasted more than three months, melatonin was never the right tool. Chronic insomnia is maintained by conditioned arousal — your brain has learned to associate the bed with wakefulness, anxiety, and frustration. No hormone supplement can unlearn that association.

Cognitive Behavioral Therapy for Insomnia (CBT-I) can. It's the only treatment with strong evidence for long-term insomnia resolution. The AASM, the ACP, and the European Sleep Research Society all recommend it as first-line therapy.

The core techniques:

• Stimulus control: rebuilding the bed = sleep association by following strict rules about when you're in bed and what you do there
• Sleep restriction: temporarily limiting time in bed to match actual sleep time, which builds sleep pressure and consolidates fragmented sleep
• Cognitive restructuring: identifying and reframing the catastrophic thoughts ("If I don't sleep tonight, tomorrow will be ruined") that fuel the arousal cycle A 2024 meta-analysis in JAMA Psychiatry found these techniques produce a large effect size (g = 0.98) — roughly ten times the effect of melatonin — and the benefits persist at 12-month follow-up without any ongoing intervention (Furukawa et al., 2024).

Digital CBT-I programs like Zomni make this protocol accessible without a 6-month waitlist for a sleep clinic. The structured, AI-guided approach means you get the same evidence-based techniques adapted to your individual sleep data.

The Bottom Line

Melatonin is not a sleeping pill. It's a circadian signal that has been marketed as a cure-all for sleep problems. If it ever seemed to work for your chronic insomnia, the effect was likely placebo — and it has faded because that's what placebo effects do.

Stop chasing higher doses. I did that for months before I figured this out. Start addressing the behavioral patterns that are actually keeping you awake. That's not something you can buy in a bottle — it's a skill you build. And unlike melatonin, it doesn't stop working after two weeks.

---

References

• Low, T. L., et al. (2022). Melatonin for sleep disorders: a Cochrane systematic review. Cochrane Database of Systematic Reviews, 5, CD012776.
• Vural, E. M., et al. (2021). Dose-response relationship of melatonin in adults with insomnia. Sleep, 44(9), zsab134.
• Cohen, P. A., et al. (2023). Melatonin content and contaminants in US dietary supplements. JAMA, 329(16), 1401-1404.
• Furukawa, T. A., et al. (2024). Component network meta-analysis of CBT for insomnia. JAMA Psychiatry, 81(3), 296-305.

References

• Furukawa, T. A., et al. (2024). Components and Delivery Formats of Cognitive Behavioral Therapy for Chronic Insomnia in Adults: A Systematic Review and Component Network Meta-analysis. JAMA Psychiatry. DOI: 10.1001/jamapsychiatry.2023.5060
• Qaseem, A., et al. (2016). Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians. Annals of Internal Medicine. DOI: 10.7326/M15-2175